Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma

Annals of Allergy, Asthma and Immunology

Volumn 88, Issue 3, 2002, Pages 306-312

  Irani, Anne Marie ^a   Cruz Rivera, Mario ^b   Fitzpatrick, Sherahe ^b   Hoag, Julie ^b   Smith, Joseph A ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOTROPIN; CROMOGLYCATE DISODIUM; HYDROCORTISONE; METHYLXANTHINE DERIVATIVE;

ADRENAL SUPPRESSION; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN TEST; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0036126273     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62013-3     Document Type: Article

References (29)

1. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
2. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in non-steroid-dependent asthmatics
3. Budesonide treatment of moderate and severe asthma in children: A dose-response study
4. Efficacy and safety of inhaled corticosteroids in asthma
5. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 1. General principles
6. Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis
7. Systemic availability and pharmacokinetics of nebulised budesonide in preschool children
8. Adrenal function in asthmatic children treated with inhaled budesonide
9. Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids
10. Pulmicort Turbuhaler 200 μg (budesonide inhalation powder) product information
11. Pharmacodynamics and pharmacokinetics of budesonide: A new nebulized corticosteroid
12. Surveillance for asthma - United States, 1960-1995
13. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants
14. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children
15. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma
16. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma
17. A quantitative assay of cortisol in human plasma by high performance liquid chromatography using a selective chemically bonded stationary phase
18. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children
19. Efficacy and safety of inhaled corticosteroids. New developments
20. Measuring efficacy and safety of different inhaled corticosteroid preparations
21. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide
22. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients
23. Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: A comparison of budesonide and beclomethasone
24. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults
25. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids
26. Assessment of cortisol secretion in children with asthma treated with inhaled steroids
27. Standard and low-dose short adrenocorticotropin test compared with insulin-induced hypoglycemia for assessment of the hypothalamic-pituitary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies
28. Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma